These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32604672)

  • 1. Supporting Active Pharmacovigilance via IT Tools in the Clinical Setting and Beyond: Regulatory and Management Aspects.
    Natsiavas P; Gavriilidis GI; Linardaki Z; Kolangi G; Gkaliagkousi E; Zamboulis C; Jaulent MC
    Stud Health Technol Inform; 2020 Jun; 272():342-345. PubMed ID: 32604672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting Social Media for Active Pharmacovigilance: The PVClinical Social Media Workspace.
    Kakalou C; Dimitsaki S; Dimitriadis VK; Natsiavas P
    Stud Health Technol Inform; 2022 Jun; 290():739-743. PubMed ID: 35673115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach.
    Gavriilidis GI; Dimitriadis VK; Jaulent MC; Natsiavas P
    Drug Saf; 2021 Nov; 44(11):1165-1178. PubMed ID: 34674190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR Data.
    Dimitriadis VK; Gavriilidis GI; Natsiavas P
    Stud Health Technol Inform; 2021 May; 281():555-559. PubMed ID: 34042637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Knowledge-Based Platform for Assessing Potential Adverse Drug Reactions at the Point of Care: User Requirements and Design.
    Natsiavas P; Jaulent MC; Koutkias V
    Stud Health Technol Inform; 2019 Aug; 264():1007-1011. PubMed ID: 31438076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
    Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
    Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacovigilance in Israel - tools, processes, and actions.
    Schwartzberg E; Berkovitch M; Dil Nahlieli D; Nathan J; Gorelik E
    Isr J Health Policy Res; 2017 Aug; 6(1):29. PubMed ID: 28760141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.
    Leporini C; Marrazzo G; Mumoli L; Esposito S; Gallelli L; Mangano G; Brancati G; De Francesco EA; Russo E; De Sarro G;
    Expert Opin Drug Saf; 2017 May; 16(5):515-522. PubMed ID: 28395523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge, Attitudes, and Practices of Pharmacovigilance and ADRs Spontaneous Reporting Among Pediatricians and Pediatric Residents in Jordan.
    Mukattash TL; Alwadi MW; Abu-Farha RK; Jarab AS; Al-Zubiedi SA; Alwedyan T
    Curr Clin Pharmacol; 2018; 13(1):45-54. PubMed ID: 29521246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance in Russia: current state of affairs, challenges, and prospects.
    Gildeeva G; Belostotsky A
    Curr Med Res Opin; 2017 Dec; 33(12):2161-2166. PubMed ID: 28562116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacovigilance in resource-limited countries.
    Olsson S; Pal SN; Dodoo A
    Expert Rev Clin Pharmacol; 2015; 8(4):449-60. PubMed ID: 26041035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.
    Carnovale C; Gentili M; Fortino I; Merlino L; Clementi E; Radice S; ViGer Group
    Expert Opin Drug Saf; 2016; 15(2):131-9. PubMed ID: 26882049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
    Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
    Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of adverse drug reactions among ordinary users of liraglutide on the occasion of drug dispensing in the community pharmacy setting.
    Christensen ST; Bjerrum OJ
    J Patient Saf; 2013 Dec; 9(4):219-23. PubMed ID: 24257065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrieval.
    Souvignet J; Declerck G; Asfari H; Jaulent MC; Bousquet C
    J Biomed Inform; 2016 Oct; 63():100-107. PubMed ID: 27369567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance in oncology: evaluation of current practice and future perspectives.
    Baldo P; De Paoli P
    J Eval Clin Pract; 2014 Oct; 20(5):559-69. PubMed ID: 24909067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.